April 17 – 22, 2026
At the AACR Annual Meeting 2026, discussions will centre on how to generate preclinical oncology data that supports successful funding milestones and enables confident development decisions.
We will be available to discuss how robust preclinical pharmacology can strengthen candidate validation by enabling detailed interrogation of mechanism, biodistribution, and therapeutic impact in clinically relevant settings. From model selection through to translational study design, the focus is on generating data that reduces uncertainty, supports informed decision-making, and clarifies next steps toward the clinic.
We are joined at the meeting by our Head of Radiotherapy and Pharmaco-Imaging, reflecting the growing role of targeted radiopharmaceuticals as a powerful pathway for validated cancer candidates.
Book a meeting and visit our booth (#3442) to explore how a scientifically rigorous approach to preclinical evaluation can help advance oncology programmes with clarity and confidence.
Not affiliated with or endorsed by AACR.
Book a meeting with our team at AACR
Meet Our Team
 |
 |
 |
 |
| Marc Hillairet De Boisferon, PhD | Eftychia Koumarianou, PhD | Teri Slack, PhD, MBA | Cédric Lamy, PhD |
| Head Of Translational Pharmacology | Head of Pharmaco-Imaging & Molecular Radiotherapy | Director, Business Development, North America, West Coast | Chief Business Officer |
Integrated comprehensive in vitro and in vivo strategies for antibody drug conjugate development
Session category: Experimental and Molecular Therapeutics
Session title: Antibody-Drug Conjugates and Linker Engineering 2
Session time: April 20th, 9:00AM – 12:00PM
Section: 13, Board number: 3, Poster number: 1706
Enhancing preclinical insights in immuno-oncology with humanized mice
Session category: Tumor Biology
Session title: Humanized Mouse Models
Session time: April 20th, 2:00 – 5:00PM
Section: 27, Board number: 10, Poster number: 3380
A fully integrated set of in vitro and in vivo tools for utilization of micro-organisms as new therapeutic weapons against cancer
Session category: Clinical Research
Session title: Vaccines and Other Immunomodulatory Agents
Session time: April 21st, 2:00 – 5:00PM
Section: 49, Board number: 11, Poster number: 6700
In vivo metastatic prostate tumor model development and follow-up progression using in vivo bioluminescence imaging
Session category: Tumor Biology
Session title: Tumor Models and Assays: In Vitro, In Vivo
Session start: April 22nd, 9:00AM – 12:00PM
Section: 32, Board number: 20, Poster number: 7539
